[Answered] Who spoke about the doctrine of justification by faith? a. Martin Luther. b. Ignatius Loyola. ...

This topic contains a solution. Click here to go to the answer

Author Question: Who spoke about the doctrine of justification by faith? a. Martin Luther. b. Ignatius Loyola. ... (Read 65 times)

Jkov05

Hero Member
Posts: 556

on: Sep 12, 2019

Question 1

The Roman Empire in the second century C.E. was divided into regions, one that spoke Latin and the other that spoke Greek.

a. True
b. False
Indicate whether the statement is true or false

Question 2

Who spoke about the doctrine of justification by faith?

a. Martin Luther.
b. Ignatius Loyola.
c. Desiderius Erasmus.
d. Albrecht Durer.
e. John Calvin.

Need homework help now?

Ask unlimited questions for free

Ask a Question

Marked as best answer by a Subject Expert

Cnarkel

Sr. Member
Posts: 339

Reply #1 on: Sep 12, 2019

Answer 1

TRUE

Answer 2

Jkov05

Member
Posts: 556

Reply 2 on: Sep 12, 2019

Thanks for the timely response, appreciate it

ktidd

Member
Posts: 319

Reply 3 on: Yesterday

Excellent

« previous next »

Did you know?

For about 100 years, scientists thought that peptic ulcers were caused by stress, spicy food, and alcohol. Later, researchers added stomach acid to the list of causes and began treating ulcers with antacids. Now it is known that peptic ulcers are predominantly caused by Helicobacter pylori, a spiral-shaped bacterium that normally exist in the stomach.

Did you know?

The strongest synthetic topical retinoid drug available, tazarotene, is used to treat sun-damaged skin, acne, and psoriasis.

Did you know?

More than one-third of adult Americans are obese. Diseases that kill the largest number of people annually, such as heart disease, cancer, diabetes, stroke, and hypertension, can be attributed to diet.

Did you know?

People with high total cholesterol have about two times the risk for heart disease as people with ideal levels.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.